Search research articles
Contact Us
Filters
Showing results (121-130 of 130) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 130 results.
Anticancer Research
|
December 30, 2023
Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse Model
Tsubasa Goshima, Katsuaki Ieguchi, Nobuyuki Onishi, et al.
Frontiers in Immunology
|
May 19, 2023
<i>Turicibacter</i> and <i>Acidaminococcus</i> predict immune-related adverse events and efficacy of immune checkpoint inhibitor
Kazuyuki Hamada, Junya Isobe, Kouya Hattori, et al.
Plos One
|
January 11, 2020
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer
Ryotaro Ohkuma, Erica Yada, Shumpei Ishikawa, et al.
Discover Oncology
|
March 18, 2025
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8<sup>+</sup> T cells as a predictor of clinical benefit
Toshiaki Tsurui, Masahiro Hosonuma, Aya Sasaki, et al.
Scientific Reports
|
October 8, 2024
MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2D<sup>Low</sup> T cells
Hitoshi Toyoda, Atsuo Kuramasu, Masahiro Hosonuma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 25, 2024
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice
Eiji Funayama, Masahiro Hosonuma, Kohei Tajima, et al.
Scientific Reports
|
May 17, 2024
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
Masakazu Murayama, Masahiro Hosonuma, Atsuo Kuramasu, et al.
Frontiers in Immunology
|
October 4, 2023
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors
Ryotaro Ohkuma, Sakiko Miura, Satoshi Muto, et al.
Cancer Immunology, Immunotherapy : CII
|
August 19, 2025
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity
Yoichiro Narikawa, Atsuo Kuramasu, Masahiro Hosonuma, et al.
Cancer Immunology, Immunotherapy : CII
|
January 27, 2024
Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer
Koji Otsuka, Junya Isobe, Yoshiyuki Asai, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 130) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 130 results.
Anticancer Research
|
December 30, 2023
Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse Model
Tsubasa Goshima, Katsuaki Ieguchi, Nobuyuki Onishi, et al.
Frontiers in Immunology
|
May 19, 2023
<i>Turicibacter</i> and <i>Acidaminococcus</i> predict immune-related adverse events and efficacy of immune checkpoint inhibitor
Kazuyuki Hamada, Junya Isobe, Kouya Hattori, et al.
Plos One
|
January 11, 2020
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer
Ryotaro Ohkuma, Erica Yada, Shumpei Ishikawa, et al.
Discover Oncology
|
March 18, 2025
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8<sup>+</sup> T cells as a predictor of clinical benefit
Toshiaki Tsurui, Masahiro Hosonuma, Aya Sasaki, et al.
Scientific Reports
|
October 8, 2024
MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2D<sup>Low</sup> T cells
Hitoshi Toyoda, Atsuo Kuramasu, Masahiro Hosonuma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 25, 2024
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice
Eiji Funayama, Masahiro Hosonuma, Kohei Tajima, et al.
Scientific Reports
|
May 17, 2024
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
Masakazu Murayama, Masahiro Hosonuma, Atsuo Kuramasu, et al.
Frontiers in Immunology
|
October 4, 2023
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors
Ryotaro Ohkuma, Sakiko Miura, Satoshi Muto, et al.
Cancer Immunology, Immunotherapy : CII
|
August 19, 2025
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity
Yoichiro Narikawa, Atsuo Kuramasu, Masahiro Hosonuma, et al.
Cancer Immunology, Immunotherapy : CII
|
January 27, 2024
Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer
Koji Otsuka, Junya Isobe, Yoshiyuki Asai, et al.
Page
of 13